PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsAcute pain
MeSH D059787 - acute pain
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010146:Pain
$
Success rate
D059787: 
Acute pain
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Hisamitsu PharmaceuticalMenthol, Methyl salicylate Salonpas 2027-08-01 2008-02-20   
Pacira BioSciencesBupivacaine Exparel  2020-11-16 $540.142 M Q2/23-Q1/24 
TrevenaOliceridine Olinvyk 2032-03-23 2020-10-30   
Clinical Trials
Historical Success Rate
Phase 1
97%
37/38
Phase 2
71%
39/55
Phase 3
70%
35/50
Approved: 3Overall Success rate: 48%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Hisamitsu Pharmaceutical
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use